Seraphim provides life sciences companies and investors with a new approach to consulting and due diligence.  Our guiding principle is that the best advice requires both rigorous scientific and technical expertise and a keen appreciation for the critical business and operational considerations.  Our expertise covers the full spectrum of the life sciences industry, including:

Biologics, Gene &
Cell Therapy

Pharmaceuticals

Medical Devices &
In Vitro Diagnostics

Contract Research & Manufacturing

Genomics, Proteomics, Research Tools, & Bioinformatics


Our Business Philosophy
Strategic Thinking, Tactical Execution™  Our experts have proven track records in both strategy and implementation.  We bring the rare ability to integrate understanding of executive level business objectives with technician level execution.  Our experts have direct operating experience with every phase of product and company development, including:

FDA / Global Regulation & Legal Issues

Product Discovery, Development & Approval Strategy

Regulatory Submissions

Manufacturing, Outsourcing, Process Development & Assessment

Technology &
Product Assessment

Intellectual Property Development
& Licensing

Business Development
& Fundraising

Marketing, Distribution & Reimbursement

Operations & Business Strategies

Our Founders

Gary Gamerman, MS, JD, President

Gary’s background covers management, regulatory and legal fields.  Prior to co-founding Seraphim, he was the EVP of Iatros Bio/Pharma Inc.  Previously, he was a FDA/CBER reviewer, and an attorney in the FDA/Life Sciences practices of two leading international law firms, where he counseled leading companies and venture firms in the development, licensing and regulation of biologics, pharmaceuticals, and medical devices.
Maureen Costello PhD, RAC Vice President–North America 
Maureen is a recognized leader in bioproduction and regulation, with extensive expertise in recombinant proteins, monoclonal antibodies and gene therapy. She has held senior management positions at SmithKline Beecham, Hoffman-La Roche and BioResponse where she was responsible for developing outsourcing programs for raw materials and APIs, technology transfer, analytical and QA/QC programs and CMC & regulatory strategy for biopharmaceuticals in all development phases.

Our Vision
Trust, Commitment, Integrity, Results  At Seraphim, these are not just words, but the core of our professional life.  We take great pride in being trusted advisors to our clients and our reputation among our peers.  Every Seraphim team member is committed to each client’s success.  Regardless of the size of the project or scope of the relationship, we treat every client consistently and with absolute integrity.